의료용 전극(Medical Electrodes) 시장은 2022년에 9억 달러였으며, 2023-2030년의 예측 기간에 CAGR 4.1%로 추이하며, 2030년에는 12억 달러에 달할 것으로 예측되고 있습니다.
의료용 전극은 내부 이온 전류의 표면 측정을 가능하게 하여 일반적으로 외과적 개입이 필요한 여러 신경, 근육, 안과, 심장 및 기타 질병의 존재를 확인하기 위해 비침습적 진단을 가능하게 합니다. 전극은 사용이 간편하고 일회용(또는 쉽게 멸균 가능)인 경우가 많으며, 전극이 지원하는 활동에서 특징적인 경우가 많습니다. 전극의 주요 기능은 환자와 활동을 측정하거나 기록하는 데 사용되는 기기 사이에 최적의 전기 접촉을 유지하는 것입니다.
게다가 세계의 의료용 전극 시장은 심혈관 및 신경계 질환의 증가, 기술 발전, 최소 침습 수술의 증가, 의료비 지출 증가, 질병 조기 발견 및 관리에 대한 인식 증가 등 다양한 요인에 의해 주도되고 있습니다.
심혈관 질환의 유병률 상승
심혈관 질환의 유병률 증가는 이러한 장애와 관련된 높은 사망률 위험으로 인해 환자의 빈번한 의료 진단 비율이 증가했기 때문에 예측 기간 동안 의료 전극 시장이 성장하는 데 도움이되는 중요한 주요 요인 중 하나입니다. 예를 들어, 미국 질병통제예방센터의 최신 팩트 시트에 따르면 80만 5천명이 40초마다 심장마비를 경험하며, 60만 5천명은 처음 경험하고 20만명은 이미 경험한 적이 있는 사람들입니다. 심장마비 5건 중 1건은 소리 없이 발생하여 당사자가 인지하지 못하는 사이에 손상을 입힙니다.
기술 진보
의료용 전극은 심장 문제를 진단하기 위해 심전도(ECG) 모니터링 시스템에 자주 사용됩니다. 심전도는 심혈관 질환 진단에 가장 널리 활용되는 검사 유형으로, 오늘날의 기술적 요구에 맞춰 검사 기술이 개선되고 있습니다. 표준 심장 홀터 및 이벤트 레코더와 달리 혁신적인 기술이 통합된 장치는 훨씬 더 비용 효율적이고 사용자 친화적입니다.
또한 전극이 소형화되고 전극 케이블이 제거됨에 따라 이제 전선이 엉키지 않고 환자의 가슴에 장치를 설치할 수 있습니다. 분석 기간 동안 의료 기기의 이러한 기술 발전은 시장 성장을 크게 향상시켰습니다.
예를 들어, 2022년 10월 5일 카네기멜론대학교의 연구원들은 뇌-컴퓨터 인터페이스 플랫폼용 마이크로 전극 어레이인 CMU 어레이를 개발했습니다. 이 솔루션은 의사가 다양한 신경 질환을 치료하는 방식을 변화시킬 것으로 기대됩니다. 이러한 혁신은 의료용 전극 시장의 채택을 강화할 것입니다.
엄격한 정부 규제
엄격한 정부 규정은 예측 기간 동안 시장 성장을 방해하는 요인 중 하나입니다. 엄격한 정부 규정은 제품의 안전, 품질 및 효능을 보장하기 위해 의료용 전극 시장에서 매우 중요합니다. 이러한 규제는 높은 수준의 유지, 혁신의 촉진, 환자 복지 보호에 도움이 됩니다. 이러한 수요 사항을 준수하는 것은 제조업체에게 중요하며 의료용 전극의 전반적인 신뢰성을 보장하는 데 도움이 됩니다.
또한 일부 신흥국과 저개발국에서는 관련 기술적 획기적인 기술과 이러한 장치의 장점에 대한 지식 부족이 예측 기간 동안 이 시장 성장을 방해할 수 있습니다.
Global Medical Electrodes Market reached US$ 0.9 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 4.1% during the forecast period 2023-2030.
Medical electrodes enable the surface measurement of internal ionic currents, resulting in a non-invasive diagnostic for several neurological, muscular, ophthalmic, cardiac, and other illnesses that would normally require surgical intervention to confirm their presence. The electrodes are often simple to use, disposable (or readily sterilizable), and often distinctive in the activities they assist with. The electrode's primary function is to maintain optimal electrical contact between the patient and the instrument used to measure or record activity.
Furthermore, the global medical electrodes market is driven by various factors like rising cardiovascular and neurological diseases, technological advancements, a rise in minimally invasive surgeries, increasing healthcare spending, and rising awareness about early disease detection and management.
Rise in the Prevalence of Cardiovascular Diseases
The rise in the prevalence of cardiovascular diseases is one of the significant key factors that helps the medical electrodes market to grow during the forecast period, owing to the high mortality risk associated with such disorders has increased the rate of frequent medical diagnosis of patients. For instance, according to the Centers for Disease Control and Prevention updated factsheet in the US, 805,000 people experience a heart attack every 40 seconds, with 605,000 being first-time cases and 200,000 being those who have already experienced one. About 1 in 5 heart attacks are silent, causing damage without the person being aware.
Rise in Technological Advancements
Medical electrodes are often used in electrocardiogram (ECG) monitoring systems to diagnose heart problems. ECG has been the most widely utilised type of diagnostics for cardiovascular diseases, and testing techniques are improving to match today's technological needs. The revolutionary technology-incorporated devices, as opposed to standard cardiac holter and event recorders, are far more cost-effective and user-friendly.
Furthermore, with the miniaturisation of electrodes and the elimination of electrode cables, devices may now be installed on the patient's chest without a tangle of wires. During the analysis period, such technical developments in medical devices considerably enhanced market growth.
For instance, on 5th October 2022, researchers at Carnegie Mellon University developed the CMU Array - a microelectrode array for brain-computer interface platforms. The solution is expected to transform the way doctors treat various neurological ailments. Such innovations will bolster the medical electrodes market adoption.
Stringent Government Regulations
Stringent government regulations are one of the restraints that hamper market growth during the forecast period. As stringent government regulations are critical in the medical electrodes market because they ensure product safety, quality, and efficacy. These regulations aid in the maintenance of high standards, the promotion of innovation, and the protection of patient well-being. Compliance with such requirements is critical for manufacturers and helps to ensure the overall reliability of medical electrodes.
Furthermore, a lack of knowledge about the associated technical breakthroughs and advantages of such devices in some emerging or underdeveloped countries may impede the growth of this market during the forecast period.
The global medical electrodes market is segmented based on product type, type, application, end-user and region.
The Diagnostic Medical Electrodes From the Product Segment Accounted for Approximately 41.7% of the Medical Electrodes Share
The diagnostic medical electrodes from the product segment with around 41.7% is expected to dominate during the forecast period owing to recent launches by key players, technological advancements will drive the segment growth. For instance, in November 2022, Brain Scientific a Florida-based medical device technology company, announced the immediate release of the improved and updated NeuroCap device and the signing of a distribution partnership with D&D Medical, Inc., to sell the company's neurology devices in Tennessee, Kentucky, Indiana, and West Virginia.
Brain Scientific developed the NeuroCap to streamline EEG prep, testing and diagnosis. NeuroCap has 22 pre-gelled electrodes making it a suitable option for most clinical EEG tests, including routine EEGs that are often used for stroke and epilepsy patients. The fixed electrode placement is in accordance with the international 10-20 system.
Geographical Penetration
North America Accounted for Approximately 38.4% of the Market Share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, due to its superior healthcare infrastructure, new launches, effective government policies, vast multinational company base, and a high level of awareness about testing and testing devices in healthcare. This region also witnesses a high prevalence of chronic inflammatory disorders, such as cardiovascular diseases, diabetes, inflammatory bowel disease (IBD), and cancer, compared to other chronic indications.
Increasing expenditure on healthcare and rising awareness among people, advancement of technologies for treatment, and increase in biopharmaceutical establishment across the region are also contributing to the growth of medical electrodes share of this region.
For instance, in May 2023 NeuroOne Medical Technologies Corporation, a medtech company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced the commercial launch of the Evo sEEG electrode product line in the United States.
The major global players in the medical electrodes market include Medtronic, Koninklijke Philips N.V., Ambu, Natus Medical Incorporated, 3M, CONMED Corporation, Rhythmlink International, LLC, Leonhard Lang GmbH, Nihon Kohden Corporation, Compumedics and among others
Segmentation
By Product Type
Electrocardiography
Electroencephalogram
Electromyography
Defibrillator
Transcutaneous Electrical Nerve Stimulation electrodes
Electrosurgical Electrodes
Neuromuscular and Muscular Electrical Stimulation (NMES)
Pacemaker electrodes
By Type
By Application
By End User
By Region
U.S.
Canada
Mexico
Germany
U.K.
France
Spain
Italy
Rest of Europe
Brazil
Argentina
Rest of South America
China
India
Japan
Australia
Rest of Asia-Pacific
The global medical electrodes report would provide approximately 53 tables, 54 figures and 195 pages.
LIST NOT EXHAUSTIVE